UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ferring’s offshoot swindled by email mimicking headquarter office
Ferring Pharmaceuticals has recently been conned out of tens of millions of...
by Nam Doo-hyun
|
2017-08-25 17:54
라인
Warning on esomeprazole compound against rhabdomyolysis
Regulators have added rhabdomyolysis – melting of cross-striated musc...
by Lee Hye-seon
|
2017-08-25 17:17
라인
Donga-ST, Kwangdong hold joint ceremony to promote ‘Contrave’
Donga-ST and Kwangdong Pharmaceutical jointly held a ceremony to promote Co...
by Lee Han-soo
|
2017-08-25 16:51
라인
Drugmakers cut entertainment expense due to anticorruption law
Almost a year after the Act on Prohibiting Illegal Solicitation, or “Kim Yo...
by Park Gi-taek
|
2017-08-25 16:27
라인
Novartis gets EU approval for breast cancer drug
Novartis AG gained European regulators’ approval Thursday for its drug Kisq...
by Marian Chu
|
2017-08-25 11:12
라인
Graminex opens Seoul office
Graminex LLC, a U.S. company known for its non-solvent rye grass flower pol...
by Marian Chu
|
2017-08-25 10:08
라인
Pharmaceutical sectors of major countries show mixed results
Korea, U.S., and Japanese pharmaceutical industries recorded trade deficits...
by Nam Doo-hyun
|
2017-08-24 18:35
라인
Quadrivalent influenza vaccines enter fierce sales competition
The competition among quadrivalent products is increasingly intensifying in...
by Nam Doo-hyun
|
2017-08-24 15:04
라인
JW Pharma revalidates diabetes safety of hyperlipidemia treatment
JW Pharmaceutical said Wednesday it has reaffirmed the safety and effective...
by Marian Chu
|
2017-08-23 12:16
라인
Triumeq aims to change HIV drug market with easy use
GSK has released Triumeq Tab. to treat human immunodeficiency virus(HIV), d...
by Nam Doo-hyun
|
2017-08-23 12:12
라인
Daewoong releases improved influenza treatment
Daewoong Pharmaceutical has released its influenza treatment Tamivict with ...
by Marian Chu
|
2017-08-23 10:34
라인
Dong-A ST, Rooyan Darou sign business alliance for biologics
Dong-A ST struck a strategic business alliance with Iranian pharmaceutical ...
by Marian Chu
|
2017-08-22 16:07
라인
2 immuno-oncology therapies receive insurance coverage
Two cancer immunotherapies -- Keytruda Inj. (pembrolizumab) and Opdivo Inj....
by Kwak Sung-sun
|
2017-08-21 15:03
라인
Amgen’s extended trial for osteoporosis treatment brings good results
Amgen Korea said Monday an extended clinical trial for its osteoporosis tre...
by Marian Chu
|
2017-08-21 14:49
라인
Boryung to improve antihypertensive drug
The Ministry of Food and Drug Safety Thursday approved Boryung Pharmaceutic...
by Marian Chu
|
2017-08-18 16:33
라인
Samyang develops multiple myeloma tablets for elderly
Samyang Biopharmaceuticals has developed Lenalidomide, a therapeutic agent ...
by Constance Williams
|
2017-08-18 12:02
라인
Pfizer gets FDA nod for lymphoid leukemia drug
The U.S. Food and Drug Administration (FDA) Thursday approved Besponsa (com...
by Constance Williams
|
2017-08-18 10:25
라인
27 ‘innovative’ drugmakers spend ₩588 billion on R&D
Twenty-seven “innovative” drugmakers invested 588.2 billion won ($517.7 mil...
by Lee Hye-seon
|
2017-08-17 16:31
라인
Takeda Korea unveils drug for ulcerative colitis, Crohn’s disease
Takeda Korea한국다케다제약 released its new drug Kynteles (compound: vedolizumab),...
by Constance Williams
|
2017-08-17 15:42
라인
SillaJen, US National Cancer Institute to conduct trials for Pexa-Vec
SillaJen신라젠 has signed a cooperative research and development agreement wit...
by Marian Chu
|
2017-08-17 15:11
-
이전
111
112
113
114
115
116
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top